GoodRx Holdings, Inc. GDRX Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 91.8%-0.9pp | 92.8%-0.7pp | 93.5%-0.2pp | 93.7%-0.2pp | 93.8%-0.1pp | |
| Operating margin | 9.9%-1.1pp | 11%+0.6pp | 10.4%-0.7pp | 11.1%+0.8pp | 10.3%+2.0pp | |
| Net margin | 2.6%-1.2pp | 3.8%-0.1pp | 4%-0.4pp | 4.3%+0.8pp | 3.6%+1.5pp | |
| EBITDA margin | 20.8%-0.8pp | 21.7%+1.2pp | 20.5%-0.3pp | 20.8%+1.2pp | 19.6%+2.5pp | |
| Free cash flow margin | 21%+0.4pp | 20.6%-1.5pp | 22.1%-1.5pp | 23.7%+4.9pp | 18.8%-4.3pp | |
| Returns | ||||||
| Return on equity | 3.2%-1.3pp | 4.5%-0.4pp | 4.9%-0.4pp | 5.3%+0.8pp | 4.4%+2.2pp | |
| Return on assets | 1.2%-0.9pp | 2.2%-0.2pp | 2.4%-0.1pp | 2.5%+0.4pp | 2.1%+1.0pp | |
| Return on invested capital | 4.3%-1.2pp | 5.5%-0.3pp | 5.8%-0.5pp | 6.3%+0.5pp | 5.7%+1.5pp | |
| Efficiency | ||||||
| Asset turnover | 0.5×-0.1× | 0.6×0.0× | 0.6×0.0× | 0.6×0.0× | 0.6×0.0× | |
| Liquidity | ||||||
| Current ratio | 1.5×-1.1× | 2.6×-0.5× | 3.1×-1.1× | 4.2×-1.0× | 5.2×-0.1× | |
| Quick ratio | 1.5×-1.1× | 2.6×-0.5× | 3.1×-1.1× | 4.2×-1.0× | 5.2×-0.1× | |
| Cash ratio | 0.3×-0.8× | 1.1×-0.4× | 1.5×-0.6× | 2.1×-0.8× | 2.9×-0.7× | |
| Leverage | ||||||
| Debt-to-equity | 0.9×0.0× | 0.9×0.0× | 0.9×+0.1× | 0.9×0.0× | 0.8×+0.1× | |
| Debt-to-assets | 0.3×-0.1× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | |
| Net debt / EBITDA | 1.9×+0.2× | 1.6×0.0× | 1.7×+0.1× | 1.6×+0.1× | 1.5×+0.8× | |
| Interest coverage | 1.9×-0.2× | 2.1×+0.1× | 1.9×-0.1× | 2×+0.3× | 1.7×+0.4× | |
| Per Share | ||||||
| Book value per share | $1.82+5.5% | $1.730.0% | $1.73-4.1% | $1.80+4.5% | $1.72-6.7% | |
| Valuation | ||||||
| Market capitalization | $934.74M-44.5% | $919.86M-37.4% | $1.47B-18.8% | $1.81B+7.0% | $1.69B-4.5% | |
| Enterprise value | $1.24B-35.4% | $1.2B-31.0% | $1.74B-16.2% | $2.08B+7.5% | $1.93B+3.5% | |
| Price / earnings | 45.5×-13.8× | 30.2×-16.1× | 46.3×-6.1× | 52.3×-7.1× | 59.5×-48.7× | |
| Price / sales | 1.2×-0.9× | 1.2×-0.7× | 1.8×-0.4× | 2.3×+0.1× | 2.1×-0.1× | |
| Price / book | 1.5×-1.0× | 1.5×-1.0× | 2.4×-0.4× | 2.8×+0.2× | 2.6×+0.1× | |
| EV / EBITDA | 7.4×-4.6× | 7×-3.7× | 10.6×-1.9× | 12.5×+0.2× | 12.4×-1.4× | |
| EV / sales | 1.5×-0.8× | 1.5×-0.7× | 2.2×-0.4× | 2.6×+0.2× | 2.4×+0.1× | |
| Free cash flow yield | 18.2%+9.1pp | 17.9%+5.8pp | 12.1%+1.6pp | 10.5%+1.6pp | 8.9%-1.5pp | |
| Earnings yield | 2.3%+0.5pp | 3.3%+1.1pp | 2.2%+0.2pp | 1.9%+0.2pp | 1.7%+0.8pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are GoodRx Holdings, Inc.'s profit margins?
- GoodRx Holdings, Inc. (GDRX) runs a 91.8% gross margin and a 9.9% operating margin, with a 2.6% net margin.
- Where do GoodRx Holdings, Inc.'s ratios come from?
- Every ratio is computed from GoodRx Holdings, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
